Advertisement

Topics

World Federation of Hemophilia (WFH) Company Profile

10:02 EST 10th December 2018 | BioPortfolio

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963, it is a global network of patient organizations in 113 countries and has official recognition from the World Health Organization. Visit WFH online at www.wfh.org.


News Articles [641 Associated News Articles listed on BioPortfolio]

ASH to Collaborate on Clinical Practice Guidelines on Diagnosis and Management of von Willebrand Disease

WASHINGTON, June 21, 2018 /PRNewswire-USNewswire/ — The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemoph...

ASH to collaborate on clinical practice guidelines of von Willebrand Disease

(American Society of Hematology) The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), Wo...

ASH to collaborate on clinical practice guidelines on von Willebrand Disease

(American Society of Hematology) The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), Wo...

BIVV001 Phase 1/2a Data Presented at ASH Underscore Potential for Once Weekly Dosing with Sustained High Factor Levels in Hemophilia A

Early data (n=2) show an unprecedented half-life of 44 hours with a single 65 IU/kg dose of BIVV001, significantly longer than the half-life observed with a short-acting recombina...

2018 International Hospital Federation Award Winners

The winners and merit awardees of the 2018 International Hospital Federation (IHF) Awards were revealed at an Awards Ceremony held at the 42nd World Hospital... The post 2018 International Hospital Fe...

FIP World Congress of Pharmacy and Pharmaceutical Sciences

NSF will be exhibiting at the seventy eigth International Pharmaceutical Federation World Congress in Glasgow, Scotland, taking place 2-6 September 2018

BioMarin Sponsors Off-Broadway Show About Hemophilia

'Hemophilia: The Musical' allows teens to share their experiences with the genetic disease.

World Seed Congress Highlights Industry's Mission to Unlock the Power of Genetics

"Innovations in plant breeding are enabling us to develop plants that meet the needs of a changing world," said Jean-Christophe Gouache, President of the International Seed Federation (ISF) during his...

PubMed Articles [1113 Associated PubMed Articles listed on BioPortfolio]

rFIXFc for Immune Tolerance Induction in a Severe Hemophilia B Patient with an Inhibitor and Prior History of ITI Related Nephrotic Syndrome.

Miracle of haemophilia drugs: Personal views about a few main players.

In the second decade of the third millennium there have been dramatic developments pertaining to the availability of highly innovative drugs for hemophilia care, notwithstanding a satisfactory previou...

Value of prophylaxis vs on-demand treatment: Application of a value framework in hemophilia.

Therapeutic advances over the past 30 years have led to longer life expectancy and improved quality of life (QOL) for persons with hemophilia. Access to innovative therapy may be compromised if treat...

Factor XI and pulmonary infections.

Recombinant activated factor VII in approved indications: Update on safety.

Clinical Trials [1610 Associated Clinical Trials listed on BioPortfolio]

World Bleeding Disorders Registry

The World Federation of Hemophilia (WFH) is conducting the pilot phase of an international, retrospective and prospective, observational, World Bleeding Disorders Registry (WBDR). This pil...

ATHN 7: Hemophilia Natural History Study

This is a real-world study of the safety of the treatments used for people with hemophilia. The study will follow people with hemophilia A or B from across the country for about 4 years as...

World Bleeding Disorders Registry

The WBDR is an international observational disease registry of patients with hemophilia. It will provide a platform for a network of hemophilia treatment centres (HTCs) around the world to...

Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry: A Nested Study Within an Existing Registry

This US study aims to assess hemophilia A patient characteristics and reasons for switching from both patient/caregiver and physician perspectives. For this purpose, this research study wi...

Study Evaluating ReFacto in Hemophilia A

To identify the causative mutations in previously untreated patients with hemophilia A enrolled in the ReFacto® clinical safety and efficacy study CTN 93-R833-0XX/C9741-28, using two esta...

Companies [728 Associated Companies listed on BioPortfolio]

World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963,...

World Federation of Hemophilia

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and other inherited bleeding di...

Hemophilia Federation of America

NORSK INDUSTRI

On 28. November 2005 the new organisation Federation of Norwegian Industries was established. The new Federation will be formally operative as of 1. January 2006. From the start, the Federation of Nor...

Bioverativ Inc.,

Bioverativ, a Sanofi company, is dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development, and commer...

More Information about "World Federation of Hemophilia (WFH)" on BioPortfolio

We have published hundreds of World Federation of Hemophilia (WFH) news stories on BioPortfolio along with dozens of World Federation of Hemophilia (WFH) Clinical Trials and PubMed Articles about World Federation of Hemophilia (WFH) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of World Federation of Hemophilia (WFH) Companies in our database. You can also find out about relevant World Federation of Hemophilia (WFH) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record